4.7 Review

Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2020.12.077

关键词

Coronavirus disease 2019; Vitamin D; Meta-analysis; Low vitamin D status; 25-hydroxyvitamin D

资金

  1. China National Science and Technology Major Project for Essential new drug research and development [2018ZX09301038-003]

向作者/读者索取更多资源

Low vitamin D status is associated with an increased risk of COVID-19, and COVID-19-positive individuals tend to have lower levels of vitamin D. However, there is significant publication bias in the existing studies.
Background: Observational studies suggest that the risk and clinical prognosis of coronavirus disease 2019 (COVID-19) are related to low vitamin D status; however, the data are inconsistent. Objectives: We conducted a systematic review and meta-analysis to assess the association between low vitamin D status and COVID-19. Methods: A systematic search was conducted with PubMed, Embase, and the Cochrane Library from database inception to September 25, 2020. The standardized mean difference (SMD) or odds ratio (OR) and corresponding 95% confidence interval (CI) was applied to estimate pooled results. Random - or fixed-effect models based on heterogeneity were used for the meta-analysis. Funnel plots and Egger regression tests were used to assess publication bias. Results: A total of ten articles with 361,934 participants were selected for meta-analysis. Overall, the pooled OR in the fixed-effect model showed that vitamin D deficiency or insufficiency was associated with an increased risk of COVID-19 (OR = 1.43, 95% CI 1.00?2.05). In addition, COVID-19-positive individuals had lower vitamin D levels than COVID-19-negative individuals (SMD = -0.37, 95% CI = -0.52 to -0.21). Significant heterogeneity existed in both endpoints. Funnel plots and Egger regression tests revealed significant publication bias. Conclusions: This systematic review and meta-analysis indicated that low vitamin D status might be associated with an increased risk of COVID-19 infection. Further studies are needed to evaluate the impact of vitamin D supplementation on the clinical severity and prognosis in patients with COVID-19. Systematic Review Registration: PROSPERO registration no: CRD42020216740. ? 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据